165 related articles for article (PubMed ID: 23086639)
1. [Cytotoxicity of homoharringtonine on leukemic stem-like cells in AML cell line KG-1].
Shen JP; Yang H; Ni WM; Qian WB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):485-90. PubMed ID: 23086639
[TBL] [Abstract][Full Text] [Related]
2. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms.
Tan M; Zhang Q; Yuan X; Chen Y; Wu Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525
[TBL] [Abstract][Full Text] [Related]
3. Homoharringtonine acts synergistically with SG235-TRAIL, a conditionally replicating adenovirus, in human leukemia cell lines.
Meng HT; Li L; Liu H; Wang Y; Li GC; Qian WB
Acta Pharmacol Sin; 2009 Nov; 30(11):1529-36. PubMed ID: 19820719
[TBL] [Abstract][Full Text] [Related]
4. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
[TBL] [Abstract][Full Text] [Related]
5. Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells.
Chen J; Mu Q; Li X; Yin X; Yu M; Jin J; Li C; Zhou Y; Zhou J; Suo S; Lu D; Jin J
Oncotarget; 2017 Jun; 8(25):40318-40326. PubMed ID: 28454099
[TBL] [Abstract][Full Text] [Related]
6. [Homoharringtonine combined arsenic trioxide induced apoptosis in human multiple myeloma cell line RPMI 8226: an experimental research].
Zhou XJ; Zhou YH; Chen XH; Qian WB
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):834-9. PubMed ID: 23980369
[TBL] [Abstract][Full Text] [Related]
7. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.
Tong H; Ren Y; Zhang F; Jin J
Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510
[TBL] [Abstract][Full Text] [Related]
8. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
[TBL] [Abstract][Full Text] [Related]
9. PEGylated long-circulating liposomes deliver homoharringtonine to suppress multiple myeloma cancer stem cells.
Li M; Shi F; Fei X; Wu S; Wu D; Pan M; Luo S; Gu N; Dou J
Exp Biol Med (Maywood); 2017 May; 242(9):996-1004. PubMed ID: 28056549
[TBL] [Abstract][Full Text] [Related]
10. Homoharringtonine induces apoptosis and growth arrest in human myeloma cells.
Lou YJ; Qian WB; Jin J
Leuk Lymphoma; 2007 Jul; 48(7):1400-6. PubMed ID: 17613769
[TBL] [Abstract][Full Text] [Related]
11. Homoharringtonine mediates myeloid cell apoptosis via upregulation of pro-apoptotic bax and inducing caspase-3-mediated cleavage of poly(ADP-ribose) polymerase (PARP).
Yinjun L; Jie J; Weilai X; Xiangming T
Am J Hematol; 2004 Jul; 76(3):199-204. PubMed ID: 15224352
[TBL] [Abstract][Full Text] [Related]
12. Homoharringtonine and SAHA synergistically enhance apoptosis in human acute myeloid leukemia cells through upregulation of TRAIL and death receptors.
Cao H; Cheng Y; You L; Qian J; Qian W
Mol Med Rep; 2013 Jun; 7(6):1838-44. PubMed ID: 23620163
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor activity of histone deacetylase inhibitor suberic bishydroxamate on acute myeloid leukemia cell lines].
Xu YH; Yang CM; Qian WB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):491-7. PubMed ID: 23086640
[TBL] [Abstract][Full Text] [Related]
14. Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines.
Wang Q; Ding W; Ding Y; Ma J; Qian Z; Shao J; Li Y
Oncotarget; 2017 Jun; 8(23):37594-37604. PubMed ID: 28410239
[TBL] [Abstract][Full Text] [Related]
15. Homoharringtonine binds to and increases myosin-9 in myeloid leukaemia.
Zhang T; Shen S; Zhu Z; Lu S; Yin X; Zheng J; Jin J
Br J Pharmacol; 2016 Jan; 173(1):212-21. PubMed ID: 26448459
[TBL] [Abstract][Full Text] [Related]
16. Bcl-xL is a dominant antiapoptotic protein that inhibits homoharringtonine-induced apoptosis in leukemia cells.
Yin S; Wang R; Zhou F; Zhang H; Jing Y
Mol Pharmacol; 2011 Jun; 79(6):1072-83. PubMed ID: 21415308
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis.
Zhang J; Chen B; Wu T; Wang Q; Zhuang L; Zhu C; Fan N; Qing W; Ma Y; Xu X
PLoS One; 2015; 10(11):e0142422. PubMed ID: 26544558
[TBL] [Abstract][Full Text] [Related]
18. Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2.
Xu B; Wang S; Li R; Chen K; He L; Deng M; Kannappan V; Zha J; Dong H; Wang W
Cell Death Dis; 2017 May; 8(5):e2797. PubMed ID: 28518151
[TBL] [Abstract][Full Text] [Related]
19. [Killing effect of aurora kinase inhibitor ENMD-2076 on acute myelogenous leukemia cells].
Cao H; Li M; Qian WB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):479-84. PubMed ID: 23086638
[TBL] [Abstract][Full Text] [Related]
20. Homoharringtonine regulates the alternative splicing of Bcl-x and caspase 9 through a protein phosphatase 1-dependent mechanism.
Sun Q; Li S; Li J; Fu Q; Wang Z; Li B; Liu SS; Su Z; Song J; Lu D
BMC Complement Altern Med; 2018 May; 18(1):164. PubMed ID: 29788973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]